<DOC>
	<DOCNO>NCT02997020</DOCNO>
	<brief_summary>The purpose study establish novel endoscopically-directed sinus potential difference ( EDSPD ) assay endpoint therapy sinus disease .</brief_summary>
	<brief_title>Ivacaftor Acquired CFTR Dysfunction Chronic Rhinosinusitis ( EDSPD Protocol )</brief_title>
	<detailed_description>The purpose study establish novel endoscopically-directed sinus potential difference ( EDSPD ) assay endpoint therapy sinus disease . This assay provide mean measure Cl- secretion across sinus epithelium human subject chronic rhinosinusitis ( CRS ) test relationship data endoscopic finding inflammation . The technique appropriate investigating acquire CFTR dysfunction sinus epithelium examine therapeutic potential CFTR potentiators CRS .</detailed_description>
	<criteria>Patient eligibility criterion design limit enrollment otherwise healthy individual schedule standardofcare nasal endoscopy clinic sinus/skull base surgery . Inclusion criterion : Age &gt; 18 year Able give consent A diagnosis CRS , determine Sinus Allergy Health Partnership criterion Has culture least one gram negative bacteria ( e.g . Pseudomonas aeruginosa , Escherichia coli , Stenotrophomonas maltophila ) within previous month Is schedule either routine endoscopic surgery previously undergone endoscopic surgery present clinic routine endoscopic evaluation Exclusion criterion : Age &lt; 18 year Unable give consent Active diagnosis cancer , autoimmune disease , know immunodeficiency Women pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>